AU2002226519A1 - Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists - Google Patents

Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists

Info

Publication number
AU2002226519A1
AU2002226519A1 AU2002226519A AU2002226519A AU2002226519A1 AU 2002226519 A1 AU2002226519 A1 AU 2002226519A1 AU 2002226519 A AU2002226519 A AU 2002226519A AU 2002226519 A AU2002226519 A AU 2002226519A AU 2002226519 A1 AU2002226519 A1 AU 2002226519A1
Authority
AU
Australia
Prior art keywords
pyrrolo
pyrimidine
receptor antagonists
purinergic receptor
purinergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002226519A
Inventor
Roger John Gillespie
Joanne Lerpiniere
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis Research Ltd
Original Assignee
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd
Publication of AU2002226519A1 publication Critical patent/AU2002226519A1/en
Abandoned legal-status Critical Current

Links

AU2002226519A 2001-01-10 2002-01-10 Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists Abandoned AU2002226519A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0100622.0 2001-01-10

Publications (1)

Publication Number Publication Date
AU2002226519A1 true AU2002226519A1 (en) 2002-07-24

Family

ID=

Similar Documents

Publication Publication Date Title
IL159832A0 (en) 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives
IL158697A0 (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
SI1220856T1 (en) Pyrazolo(4,3-d)pyrimidine derivatives
AU2002327168A1 (en) Pyrrolo(2,3-d)pyrimidine nucleoside analogs
AU7367001A (en) Pyrido(2,3-d)pyrimidine and pyrimido(4,5-d)pyrimidine nucleosides
HUP0400692A3 (en) Substituted 7h-pyrrolo[2,3-d]pyrimidine derivatives, their use and pharmaceutical compositions containing them
HK1036800A1 (en) Pyrrolo(2,3-d)pyrimidine compounds, its composition and use thereof
PT1382339E (en) Compositions containing pyrrolo ¬2,3-d pyrimidine derivatives
AU2003265636A1 (en) Pyrrolo(2, 3-d)pyrimidine-4-yl and purin-6-yl urea compounds
HUP0402270A3 (en) [1,2,4]triazolo[1,5-c]pyrimidin-5-yl-amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
AU2003292007A1 (en) 4-AMINO-5-PHENYL-7-CYCLOHEXYL-PYRROLO(2,3-d)PYRIMIDINE DERIVATIVES
IL160402A0 (en) Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido {1,2-a} pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-pyrimidin-5 (1h) one derivatives
IL161573A0 (en) [1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
PL353366A1 (en) Pyrazolo[4,3-d]pyrimidines
HUP0303005A3 (en) Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists
IL160084A0 (en) Thieno [2,3-d] pyrimidines with combined la and fsh agonistic activity
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
AU2002215979A1 (en) Use of pyrazolo(4,3-D)pyrimidines
AU2002216033A1 (en) Use of pyrazolo(4,3-d)pyrimidines
AU2002226519A1 (en) Pyrrolo(2,3-d)pyrimidine and their use as purinergic receptor antagonists
AU8578501A (en) 2-aminoalkyl-thieno(2,3-d)pyrimidines
AU2001285785A1 (en) 2-aminoalkyl-thieno[2,3-d]pyrimidines
AU2002219350A1 (en) Pyrazolo(3,4-d)pyrimidine derivatives and their use as purinergic receptor antagonists
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
AU2002217336A1 (en) Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists